Cargando…

Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly

BACKGROUND: Asprosin is a novel identified adipokine secreted mainly by white adipose tissue, which is elevated in metabolic diseases such as diabetes and obesity. Acromegaly is a syndrome caused by pituitary growth hormone (GH) cell adenoma with excessive GH secretion. Serum adipocytokines levels m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Xiaoan, Duan, Lian, Gong, Fengying, Zhang, Yuelun, Deng, Kan, Yao, Yong, Wang, Linjie, Pan, Hui, Zhu, Huijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752286/ https://www.ncbi.nlm.nih.gov/pubmed/33414826 http://dx.doi.org/10.1155/2020/8855996

Ejemplares similares

Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study
por: Xiao, Tongxin, et al.
Publicado: (2023)

The Negative Impacts of Acromegaly on Bone Microstructure Not Fully Reversible
por: Duan, Lian, et al.
Publicado: (2021)

Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue
por: Miao, Yanli, et al.
Publicado: (2021)

Safety of pregnancy in acromegaly patients and maternal and infant outcomes after pregnancy: single-center experience from China and review of the literature
por: Jiao, Rui, et al.
Publicado: (2023)

The side effects of dopamine receptor agonist drugs in Chinese prolactinoma patients: a cross sectional study
por: Ke, Xiaoan, et al.
Publicado: (2022)

The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review
por: Chen, Meiping, et al.
Publicado: (2021)

Nuciferine Inhibited the Differentiation and Lipid Accumulation of 3T3-L1 Preadipocytes by Regulating the Expression of Lipogenic Genes and Adipokines
por: Xu, Hanyuan, et al.
Publicado: (2021)

Sensitive asprosin detection in clinical samples reveals serum/saliva correlation and indicates cartilage as source for serum asprosin
por: Morcos, Yousef A. T., et al.
Publicado: (2022)

Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Corrigendum: Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH
por: Chen, Meiping, et al.
Publicado: (2022)

Increased serum asprosin is correlated with diabetic nephropathy
por: Wang, Rui, et al.
Publicado: (2021)

Serum Asprosin Correlates with Indirect Insulin Resistance Indices
por: Mirr, Małgorzata, et al.
Publicado: (2023)

Asprosin in pregnancy and childhood
por: Janoschek, Ruth, et al.
Publicado: (2020)

Serum concentration of asprosin in new-onset type 2 diabetes
por: Naiemian, Shakiba, et al.
Publicado: (2020)

High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome
por: Hong, Tao, et al.
Publicado: (2021)

MON-LB082 Elevated Expression of KISSR Is Associated with Secretory Function of Functioning Gonadotroph Adenomas
por: Wang, Linjie, et al.
Publicado: (2019)

Efficacy and adverse events of octreotide long-acting release in acromegaly: a real-world retrospective study
por: Zhao, Zhe, et al.
Publicado: (2022)

Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes
por: Deng, Xia, et al.
Publicado: (2020)

The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
por: Chang, Chia Lin, et al.
Publicado: (2019)

Metabolic syndrome as a common comorbidity in adults with hypothalamic dysfunction
por: Xu, Zhuoran, et al.
Publicado: (2022)

The role of Asprosin in patients with dilated cardiomyopathy
por: Wen, Ming-Shien, et al.
Publicado: (2020)

Acromegaly complicated with fulminant pituitary apoplexy: clinical characteristic analysis and review of literature
por: Zheng, Xue-Qing, et al.
Publicado: (2023)

Serum Asprosin Concentrations in Children with Prader–Willi Syndrome: Correlations with Metabolic Parameters
por: Alsaif, Maha, et al.
Publicado: (2022)

Serum ZAG and Adiponectin Levels Were Closely Related to Obesity and the Metabolically Abnormal Phenotype in Chinese Population
por: Liu, Meijuan, et al.
Publicado: (2020)

Distinct AMPK-Mediated FAS/HSL Pathway Is Implicated in the Alleviating Effect of Nuciferine on Obesity and Hepatic Steatosis in HFD-Fed Mice
por: Xu, Hanyuan, et al.
Publicado: (2022)

Asprosin induces vascular endothelial-to-mesenchymal transition in diabetic lower extremity peripheral artery disease
por: You, Mei, et al.
Publicado: (2022)

Serum Asprosin Level as a New Biomarker in Differentiating Familial Mediterranean Fever Attacks
por: Sipahioglu, Hilal, et al.
Publicado: (2023)

Asprosin is a centrally-acting orexigenic hormone
por: Duerrschmid, Clemens, et al.
Publicado: (2017)

Asprosin: A Novel Player in Metabolic Diseases
por: Yuan, Mingyang, et al.
Publicado: (2020)

The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases
por: Liu, Lifei, et al.
Publicado: (2022)

Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease
por: Liu, Meijuan, et al.
Publicado: (2019)

Serum Zinc-α2-Glycoprotein Levels in Patients with or without Coronary Artery Disease in Chinese North Population
por: Liu, Meijuan, et al.
Publicado: (2020)

Diet and exercise interventions reduce serum asprosin and the corresponding hypothalamic– pituitary–gonad-axis dysfunction in obese men
por: Yao, Tingting, et al.
Publicado: (2022)

Asprosin—A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature
por: Mazur-Bialy, Agnieszka Irena
Publicado: (2021)

Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
por: Ugur, Kader, et al.
Publicado: (2019)

The Asprosin–OLFR734 module regulates appetitive behaviors
por: Liu, Yang, et al.
Publicado: (2020)

Asprosin-neutralizing antibodies as a treatment for metabolic syndrome
por: Mishra, Ila, et al.
Publicado: (2021)

The Role of Meteorin-Like Peptide and Asprosin in Colon Carcinoma
por: Onat, Elif, et al.
Publicado: (2023)

Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults
por: Zhu, Huijuan, et al.
Publicado: (2017)

The Value of 4D Speckle-Tracking Strain Echocardiography in Evaluating the Relationship Between Asprosin and Growth Differentiation Factor-15 Levels and Subclinical Systolic Dysfunction in Patients With Acromegaly and Prolactinoma
por: Firlatan, Busra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vfscaov8jqi5hb14ptgiutsh5f